Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Neoplasma. 2013;60(3):290-4. doi: 10.4149/neo_2013_038.
Triple-negative breast cancer (TNBC) relapses more frequently than hormone receptor-positive subtypes and is often associated with poor outcomes. This retrospective study reviewed the pattern of distant metastasis with regard to survival in patients with TNBC. A total of 205 TNBC patients were analyzed. TNBC patients with lung metastases had the longest median post-metastatic OS (with 95% confidence interval) of 16.6 (10.3-22.9) months, followed by the bone, 16.3 (11.7-20.8) months, the liver, 8.9 (3.5-14.4) months, the pleura, 7.5 (2.8-12.3) months, and the brain, 4.3 (0.6-8.0) months. Kaplan-Meier plots indicated that TNBC patients with metastatic spread to brain, liver, and pleural had poorer post-metastatic OS rate than patients with lung metastases (p = 0.001, 0.004, and 0.029, respectively). Moreover, brain and liver metastases correlated significantly with poorer post-metastatic OS as compared to bone metastasis (p = 0.004 and 0.011, respectively). Route of first metastasis correlated significantly with survival of TNBC patients with brain metastases being the poorest survival indicator, followed by metastases to liver, pleura, bone, and lung.
三阴性乳腺癌(TNBC)比激素受体阳性亚型更容易复发,并且通常与不良预后相关。本回顾性研究分析了 TNBC 患者远处转移与生存的关系模式。共分析了 205 例 TNBC 患者。发生肺转移的 TNBC 患者的中位无进展生存期(95%置信区间)最长,为 16.6(10.3-22.9)个月,其次是骨转移,为 16.3(11.7-20.8)个月,肝转移为 8.9(3.5-14.4)个月,胸膜转移为 7.5(2.8-12.3)个月,脑转移为 4.3(0.6-8.0)个月。Kaplan-Meier 图表明,与发生肺转移的患者相比,发生脑转移、肝转移和胸膜转移的 TNBC 患者的无进展生存期(post-metastatic OS)率更差(p=0.001、0.004 和 0.029)。此外,脑转移和肝转移与无进展生存期显著相关,与骨转移相比(p=0.004 和 0.011)。首次转移途径与 TNBC 脑转移患者的生存显著相关,脑转移的生存预后最差,其次是肝转移、胸膜转移、骨转移和肺转移。